Delivery Order SPE2DB22D3010-SPE2DB25FP2XY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery under the company's existing relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award based on open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count package) on September 22, 2025, with completion expected by October 14, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28 units) on August 15, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award under the company's broader pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) on September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of October 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count units) under a firm fixed-price contract valued at $6,007.90. The award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery against AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed-price contract valued at $12,015.80, with completion scheduled by September 9, 2025. This is a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP2XYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (quantity 28) on July 11, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside contract represents a direct pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location, reflecting the vendor's role as a critical pharmaceutical distributor for the federal government. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this arrangement, the company provides critical pharmaceuticals to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/11/25 |